IRF8 and myeloid sarcoma: Recent studies have suggested that interferon regulatory factor 8 may serve as a novel immunological biomarker for MS.[15] When morphology and immunophenotyping are inconclusive, cytogenetic and molecular analyses can provide critical diagnostic information.